GE Buys Wave Biotech

It pushes into biopharmaceuticals.
Author:
Publish date:

General Electric (GE) - Get Report acquired Wave Biotech in a bid to build up its biopharmaceuticals manufacturing services arm.

GE Healthcare said Wave has 70 workers and annual revenue of $25 million. It operates a Somerset, N.J.-based research-and-development center. The company focuses on building disposable bioreactors for the manufacture of antibodies and vaccines.